Target intelligence / Profile preview

Short-chain fatty acid metabolism

Molecular classification
Other
01

Overview

Short-chain fatty acid metabolism" refers to the collective biochemical processes by which short-chain fatty acids (SCFAs)—primarily acetate, propionate, and butyrate—are produced and utilized in the body. These SCFAs are generated mainly through microbial fermentation of dietary fibers in the colon[1][3][5]. They serve as key energy sources for colonocytes, regulate glucose and lipid homeostasis, modulate appetite via gut hormones such as GLP1 and PYY, influence immune responses by promoting T regulatory cell differentiation and cytokine production, enhance intestinal barrier function by supporting tight junction assembly, and play a role in maintaining overall intestinal health[1][2][3][4][5]. SCFA signaling is mediated through G protein-coupled receptors such as GPR41/43 on various cell types[4]. Altered SCFA levels or dysregulated metabolism have been implicated in diseases including metabolic syndrome, inflammatory bowel disease, neurodegenerative conditions via the gut-brain axis connection, and certain cancers[1][2][3]. Note: "Short-chain fatty acid metabolism" is not a single molecule or receptor but rather a metabolic process involving multiple enzymes/pathways. It is not considered a canonical therapeutic target like an enzyme or receptor; instead it describes a physiological system/process. If you are seeking information about specific molecular targets within this pathway—such as G protein-coupled receptors for SCFAs (GPR41/FFAR3 or GPR43/FFAR2), transporters like MCTs (monocarboxylate transporters), or enzymes involved in their synthesis/utilization—those should be specified individually for structured data extraction[4].

Other names
SCFA metabolismshort-chain fatty acids metabolismSCFAs metabolic pathway
02

Biological functions

Energy productionRegulation of glucose and lipid metabolismAppetite regulationImmune modulationMaintenance of gut barrier integrityModulation of inflammation
03

Disease associations

InflammationMetabolic disease (e.g., diabetes, obesity)Gastrointestinal disorders (e.g., inflammatory bowel disease)Neurodegenerative disease (via gut-brain axis)Cancer (especially colorectal cancer)

Beyond the preview

Go deeper on Short-chain fatty acid metabolism.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Short-chain fatty acid metabolism.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call